Reata Pharmaceuticals (NASDAQ:RETA) Sets New 12-Month High at $170.83

Reata Pharmaceuticals, Inc. (NASDAQ:RETA – Get Free Report) reached a new 52-week high on Monday . The company traded as high as $170.83 and last traded at $170.83, with a volume of 25211 shares traded. The stock had previously closed at $170.32. Analysts Set New Price Targets A number of research firms have weighed in […]

Related Keywords

Leerink Partnrs ,Carter Bir ,Nasdaq ,Wells Fargo Company ,Reata Pharmaceuticals Inc ,Reata Pharmaceuticals Trading ,Citigroup ,Reata Pharmaceuticals ,Affinity Asset Advisors ,News Ratings For Reata Pharmaceuticals Daily ,Securities Exchange Commission ,Visionpoint Advisory Group ,Institutional Trading Of Reata Pharmaceuticals ,Get Free Report ,Dawn Carter Bir ,Exchange Commission ,Director Shamim Ruff ,Point Advisory Group ,Asset Advisors ,Wells Fargo ,Reata Pharmaceuticals Daily ,Nasdaq Reta ,Greta ,Medical ,Stocks ,Technicals ,